The big bets are on RNA, DNA, and mRNA vaccines. All money has gone to those companies.
GNBT is still off the radar. All eyes are on those other companies billions have been poured into. So far no DNA, RNA vaccines for anything have ever been successful.
Not surprised it is selling like this. Kind of like the show me state, Missouri, then I'll stop selling and buy in. Overseas deals get cemented then things could change quickly for Generex. BARDA will look like fools.
And if GNBT does come through with a kick ass vaccine that has long lasting memory that other countries are using while operation "warped speed" flounders....... well, again this administration has pit all its eggs in the wrong basket. Big pharma does not always rock.
News 
Market Data 
Discover 
